UNSPSC 85812138: Introduction of other antineoplastic into nose, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into nose, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E09305

UNSPSC 85812138 Introduction of other antineoplastic into nose, percutaneous approach, Commodity, shows no meaningful recent activity aligned with its stated scope. The code nominally describes a clinical procedure — intranasal chemotherapy administration — yet the recent opportunities tagged to this code span telehealth urgent care, nursing home operations, cancer registry services, occupational health screening, opioid use disorder treatment, and employee wellness platforms. None of these solicitations involve antineoplastic drug delivery or percutaneous nasal procedures.

The mismatch suggests either systematic miscoding in the source jurisdictions or that state and local procurement databases are tagging health services broadly under this code without regard to specificity. The issuing bodies span state health authorities (Nevada Health Authority, Colorado Department of Human Services), counties (DeKalb, Forsyth, Sedgwick, Ventura, Santa Clara, San Mateo, Jackson), cities (Atlanta, Phoenix, Ocala), and regional consortia (Sourcewell). Geographic activity concentrates in California, Texas, Georgia, Florida, and Colorado, with scattered activity in Nevada, New Jersey, Kansas, and other states. Without recent solicitations actually seeking the chemotherapy procedure the code describes, this code presents limited opportunity for vendors offering antineoplastic services or percutaneous delivery systems.